Gene · 218
Papers1,555
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,555
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of Small Airway Epithelium-Related Hub Genes in Chronic Obstructive Pulmonary Disease. | Int J Chron Obstruct Pulmon Dis | 2022 | 36475041 | PubTator, text mining | PubMed |
| Genome-Wide RNA Sequencing of Human Trabecular Meshwork Cells Treated with TGF-β1: Relevance to Pseudoexfoliation Glaucoma. | Biomolecules | 2022 | 36421707 | PubTator, text mining | PubMed |
| Long noncoding RNA DIO3OS induces glycolytic-dominant metabolic reprogramming to promote aromatase inhibitor resistance in breast cancer. | Nat Commun | 2022 | 36418319 | PubTator, text mining | PubMed |
| Electrospun-Reinforced Suturable Biodegradable Artificial Cornea. | ACS Appl Bio Mater | 2022 | 36416454 | PubTator, text mining | PubMed |
| Intimate intertwining of the pathogenesis of hypoxia and systemic sclerosis: A transcriptome integration analysis. | Front Immunol | 2022 | 36389675 | PubTator, text mining | PubMed |
| Construction and validation of a m6A RNA methylation and ferroptosis-related prognostic model for pancreatic cancer by integrated bioinformatics analysis. | J Gastrointest Oncol | 2022 | 36388690 | PubTator, text mining | PubMed |
| Super-enhancers in esophageal carcinoma: Transcriptional addictions and therapeutic strategies. | Front Oncol | 2022 | 36387198 | PubTator, text mining | PubMed |
| Role of SUMOylation in Neurodegenerative Diseases. | Cells | 2022 | 36359791 | PubTator, text mining | PubMed |
| Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma. | Cancers (Basel) | 2022 | 36358885 | PubTator, text mining | PubMed |
| Pharmacogenetics of Drug Metabolism: The Role of Gene Polymorphism in the Regulation of Doxorubicin Safety and Efficacy. | Cancers (Basel) | 2022 | 36358854 | PubTator, text mining | PubMed |
| A Whole New Comprehension about ncRNA-Encoded Peptides/Proteins in Cancers. | Cancers (Basel) | 2022 | 36358616 | PubTator, text mining | PubMed |
| Epigenetic Alterations of Repeated Relapses in Patient-matched Childhood Ependymomas. | Nat Commun | 2022 | 36335125 | PubTator, text mining | PubMed |
| Dysregulation of SOX17/NRF2 axis confers chemoradiotherapy resistance and emerges as a novel therapeutic target in esophageal squamous cell carcinoma. | J Biomed Sci | 2022 | 36310172 | PubTator, text mining | PubMed |
| Targeting aldehyde dehydrogenase for prostate cancer therapies. | Front Oncol | 2022 | 36300093 | PubTator, text mining | PubMed |
| Collagen Alignment via Electro-Compaction for Biofabrication Applications: A Review. | Polymers (Basel) | 2022 | 36297848 | PubTator, text mining | PubMed |
| Recent Advancements in Molecular Therapeutics for Corneal Scar Treatment. | Cells | 2022 | 36291182 | PubTator, text mining | PubMed |
| Exosomes Released by Corneal Stromal Cells Show Molecular Alterations in Keratoconus Patients and Induce Different Cellular Behavior. | Biomedicines | 2022 | 36289615 | PubTator, text mining | PubMed |
| A noncanonical function of EIF4E limits ALDH1B1 activity and increases susceptibility to ferroptosis. | Nat Commun | 2022 | 36274088 | PubTator, text mining | PubMed |
| Deciphering the roadmap of in vivo reprogramming toward pluripotency. | Stem Cell Reports | 2022 | 36270281 | PubTator, text mining | PubMed |
| Ferroptosis regulator SLC7A11 is a prognostic marker and correlated with PD-L1 and immune cell infiltration in liver hepatocellular carcinoma. | Front Mol Biosci | 2022 | 36267158 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/218/papers?page=13